December 5th 2024
Many factors must be considered to overcome the challenges associated with viral clearance.
The authors evaluated the potential of direct filtration for multiple biopharmaceutical candidates. This article is Part 2 of the study.
Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series
April 3rd 2019Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.
INTERPHEX 2019 Keynote Series Presents Session on 3D Printing in Pharma
April 2nd 20193D printing offers a new design freedom for bio/pharmaceutical manufacturing: whether for “printing” a solid-dosage drug or for creating a piece of equipment for bio/pharmaceutical laboratories or manufacturing facilities.
Fujifilm, CPI Collaborate on New Technologies for MAb Downstream Processing
November 5th 2018Fujifilm Diosynth Biotechnologies and the Centre for Process Innovation (CPI) are collaborating to complete the technology transfer of the expression and purification of model monoclonal antibodies (mAbs) as part of AMECRYS, a research project funded by the European Commission.
Improving Aggregate Removal to Enhance Clinical Manufacturing of MAbs
September 28th 2018Hydrophobic interaction chromatography (HIC) in flow-through mode offers a more efficient and cost-effective polishing/purification process to remove monoclonal antibody aggregates while maintaining purity at ≥99% than a mixed-mode bind/elute procedure.